- Zacks•22 hours ago
GW Pharmaceuticals (GWPH) reported a narrower-than-expected loss of 89 cents per share in the fourth quarter of fiscal 2016 (ended Sep 30, 2016).
- Motley Fool•yesterday
GW Pharmaceuticals' revenue tumbled in its fiscal fourth quarter, but investors might be better off focusing on the company's future opportunity for sales growth rather than its past.
- Investor's Business Daily•2 days ago
GW Pharma reported more positive phase 3 trial results for its cannabis-based drug targeting rare forms of epilepsy, but sales missed and losses rose.
GWPH : Summary for GW Pharmaceuticals Plc - Americ - Yahoo Finance
GW Pharmaceuticals plc (GWPH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||102.67 x 100|
|Ask||132.85 x 100|
|Day's Range||116.09 - 120.49|
|52 Week Range||107.10 - 130.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-35.77|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|